超声引导下局部甲氨蝶呤注射治疗宫颈妊娠
回顾性分析15例宫颈妊娠患者接受经阴道超声引导下局部甲氨蝶呤注射作为初始治疗。所有15例均治疗成功,无需输血或手术;3例因血清hCG下降不佳需追加局部注射,1例因持续阴道出血及妊娠囊增大需子宫动脉栓塞。10例有再孕意愿者中7例妊娠顺利。
要点
- 经阴道超声引导下局部甲氨蝶呤单次注射可作为宫颈妊娠的初始治疗选择。
- 15例均治疗成功,无需输血或手术;3例需追加局部注射,1例需子宫动脉栓塞。
- hCG正常化平均时间43.8天(95%CI 33.3-54.3),月经恢复平均68.4天(95%CI 51.9-84.9)。
核心结论
- 单次超声引导下局部甲氨蝶呤注射对宫颈妊娠治疗似乎有效,无需伴随操作或手术干预,且保留生育功能并允许后续顺利妊娠的可能。
研究设计与样本
- 回顾性研究,纳入15例宫颈妊娠患者,均接受经阴道超声引导下局部甲氨蝶呤注射治疗。
- 治疗后监测血清人绒毛膜促性腺激素(hCG)水平及超声评估妊娠囊,必要时行磁共振成像(MRI)。
主要发现
- 甲氨蝶呤注射时中位估计孕龄为6+2周(范围5+2至11+0周)。
- 15例均治疗成功,无需输血或手术;3例因初始注射后血清hCG下降不佳需追加局部甲氨蝶呤注射,1例因持续阴道出血及对比增强MRI可见血管的妊娠囊增大需子宫动脉栓塞。
- 初始甲氨蝶呤注射后hCG正常化平均时间43.8天(95%CI 33.3-54.3),月经恢复平均时间68.4天(95%CI 51.9-84.9)。
- 10例治疗后希望后续妊娠的妇女中,7例妊娠顺利,1例妊娠但于孕8周自然流产,1例诊断输卵管妊娠后行腹腔镜手术,1例未受孕。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cervical pregnancy (CP) is a rare type of ectopic pregnancy. While methotrexate (MTX) is generally the first-line method of choice for clinically stable women, there is still no consensus on the most appropriate treatment for this abnormal pregnancy. The aim of this study was to investigate the efficacy of a single local MTX injection under transvaginal ultrasound guidance for the initial treatment of CP and to assess post-treatment fertility. METHODS: We reviewed retrospectively 15 patients with CP treated with local MTX injection under transvaginal ultrasound guidance. In all patients, the serum human chorionic gonadotropin (hCG) levels were monitored and the gestational sac was evaluated using ultrasonography after treatment. Magnetic resonance imaging (MRI) was performed as necessary. We evaluated the patients' clinical characteristics and clinical course after treatment, the efficacy of the treatment and the post-treatment fertility in patients desiring subsequent pregnancy. RESULTS: The median estimated gestational age at the time of MTX injection was 6 + 2 (range, 5 + 2 to 11 + 0) weeks. All 15 patients were treated successfully, without the need for blood transfusion or surgical procedures; however, three patients required an additional local MTX injection due to a poor decline in serum hCG level following the initial injection, while one patient required uterine artery embolization due to persistent vaginal bleeding and an enlarging gestational sac with blood vessels visible on contrast-enhanced MRI. The mean time following initial MTX injection for hCG normalization was 43.8 (95% CI, 33.3-54.3) days and for resumption of menses was 68.4 (95% CI, 51.9-84.9) days. Seven of the 10 women desiring subsequent pregnancy following treatment had uneventful pregnancy, one became pregnant but miscarried spontaneously at 8 weeks of gestation, one was treated by laparoscopic surgery after diagnosis of a tubal pregnancy and one did not conceive. CONCLUSIONS: A single, ultrasound-guided, local MTX injection is apparently effective for the treatment of CP without the need for concomitant procedures or surgical intervention. Furthermore, this conservative technique both preserves fertility and allows for the possibility of subsequent uneventful pregnancy. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Yamaguchi M, Honda R, Erdenebaatar C, et al. Treatment of cervical pregnancy with ultrasound-guided local methotrexate injection. Ultrasound Obstet Gynecol. 2017. PMID: 27943496. doi:10.1002/uog.17384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。